1 | RPRX | Royalty Pharma plc | 4.00% |
2 | VTRS | Viatris Inc. | 3.92% |
3 | PFE | Pfizer Inc. | 3.90% |
4 | ELAN | Elanco Animal Health Incorporated | 3.89% |
5 | MRK | Merck & Co., Inc. | 3.86% |
6 | OGN | Organon & Co. | 3.79% |
7 | JNJ | Johnson & Johnson | 3.77% |
8 | CORT | Corcept Therapeutics Incorporated | 3.77% |
9 | PRGO | Perrigo Company plc | 3.75% |
10 | JAZZ | Jazz Pharmaceuticals plc | 3.75% |
11 | TARS | Tarsus Pharmaceuticals, Inc. | 3.70% |
12 | LLY | Eli Lilly and Company | 3.63% |
13 | AXSM | Axsome Therapeutics, Inc. | 3.62% |
14 | ZTS | Zoetis Inc. | 3.60% |
15 | PBH | Prestige Consumer Healthcare Inc. | 3.55% |
16 | BMY | Bristol-Myers Squibb Company | 3.53% |
17 | HRMY | Harmony Biosciences Holdings, Inc. | 2.77% |
18 | PCRX | Pacira BioSciences, Inc. | 2.49% |
19 | ANIP | ANI Pharmaceuticals, Inc. | 2.37% |
20 | AMRX | Amneal Pharmaceuticals, Inc. | 2.25% |
21 | SUPN | Supernus Pharmaceuticals, Inc. | 2.05% |
22 | OCUL | Ocular Therapeutix, Inc. | 2.01% |
23 | XERS | Xeris Biopharma Holdings, Inc. | 1.94% |
24 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.94% |
25 | INVA | Innoviva, Inc. | 1.93% |
View XPH holdings |